Pharmaceutical-Biotech Industry Places 29 North American Manufacturing Plants on Chopping Block
Pharmaceutical-Biotech Industry Places 29 North American Manufacturing Plants on Chopping Block
Attachment: Pharma-related Plant Closures
SUGAR LAND--March 31, 2015--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--In a case of bad news being not quite as bad as it could be, the Pharmaceutical-Biotech Industry has targeted 29 sites across North America for closure. What makes this not quite such bad news is how low the number itself actually is.
Within this article: Details on how and why the number of Pharmaceutical-Biotech plant closures has abated.
Companies featured: Pfizer Incorporated (NYSE:PFE)
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- U.S. Supplement Production Brings Millions in Spending
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips